adalimumab

	adalimumab
Trade Name
Orphan Indication	Behçet’s Disease
USA Market Approval	USA
USA Designation Date	2014-07-10 00:00:00
Sponsor	Mucora;32b Eisenberg St, Rehovot 7628810;